ZBIO Competitors & Alternatives
Compare Zenas BioPharma, Inc. Common Stock with similar stocks in the same industry
Biotechnology
ZBIO
Main Stock$19.80
Tradestie Score
66
Market Cap
$931.48M
Revenue Growth
-1.0%
Analyst Upside
+112.8%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PGEN
Precigen, Inc. Common Stock
|
$4.45
|
$1.18B | - | 53 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$46.13
|
$1.17B | - | 58 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$22.74
|
$1.15B | 3.6 | 61 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$14.21
|
$1.14B | - | 60 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$8.27
|
$1.14B | - | 59 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$24.05
|
$1.13B | - | 51 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$5.87
|
$1.12B | - | 54 | Compare |
|
NKTR
Nektar Therapeutics
|
$59.38
|
$1.12B | - | 52 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$266.58
|
$1.12B | - | 55 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$9.38
|
$1.09B | - | 51 | Compare |
More ZBIO Analysis
Data updated: Jun 13, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry